Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius Medical Care AG & Co. KGaA    FME   DE0005785802

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Fresenius Medical Care AG & Co. KGaA : Notification and public disclosure of transactions by persons

share with twitter share with LinkedIn share with facebook
05/08/2020 | 10:45am EDT


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

08.05.2020 / 16:39
The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Title:
First name: Rice
Last name(s): Powell

2. Reason for the notification

a) Position / status
Position: Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
Fresenius Medical Care AG & Co. KGaA

b) LEI
549300CP8NY40UP89Q40 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
ISIN: DE000A254VN2

b) Nature of the transaction
Exercise of stock options on Fresenius Medical Care shares of the stock option plan and sale of the shares (cash settlement)
Transaction linked to the exercise of share option programmes

c) Price(s) and volume(s)
Price(s) Volume(s)
69.51 EUR 973557.06 EUR

d) Aggregated information
Price Aggregated volume
69.51 EUR 973557.06 EUR

e) Date of the transaction
2020-05-07; UTC+2

f) Place of the transaction
Outside a trading venue



08.05.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
Internet: www.freseniusmedicalcare.com

 
End of News DGAP News Service

59561  08.05.2020 

© EQS 2020

share with twitter share with LinkedIn share with facebook
All news about FRESENIUS MEDICAL CARE AG & CO. KGAA
10/23FRESENIUS SE : Receives a Buy rating from Goldman Sachs
MD
10/23FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Buy rating from Goldman Sachs
MD
10/22FRESENIUS SE : Credit Suisse reiterates its Neutral rating
MD
10/22FMC FRESENIUS MEDICAL CARE AG & CO K : Credit Suisse reaffirms its Neutral ratin..
MD
10/22FMC FRESENIUS MEDICAL CARE AG & CO K : Credit Suisse remains Neutral
MD
10/21FRESENIUS SE : Berenberg reiterates its Buy rating
MD
10/21Vifor Pharma and Cara Therapeutics sign US license agreement for IV Korsuva t..
AQ
10/21FRESENIUS SE : Barclays reiterates its Buy rating
MD
10/21FMC FRESENIUS MEDICAL CARE AG & CO K : Receives a Buy rating from Barclays
MD
10/20FRESENIUS MEDICAL CARE : gets FDA approval for Biofine® PD solution bags
PU
More news
Financials (USD)
Sales 2020 21 505 M - -
Net income 2020 1 543 M - -
Net Debt 2020 14 311 M - -
P/E ratio 2020 15,4x
Yield 2020 1,74%
Capitalization 23 836 M 23 792 M -
EV / Sales 2020 1,77x
EV / Sales 2021 1,66x
Nbr of Employees 124 736
Free-Float 65,1%
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 99,54 $
Last Close Price 81,40 $
Spread / Highest target 41,4%
Spread / Average Target 22,3%
Spread / Lowest Target -1,84%
EPS Revisions
Managers
NameTitle
Rice Powell Chairman-Management Board
Dieter Schenk Chairman-Supervisory Board
Helen Giza Chief Financial Officer
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Global Chief Medical Officer